Benzinga | Nov 12, 2021 07:43AM EST

Meridian Bioscience Q4 Adj. EPS $0.23 Beats $0.20 Estimate, Sales $76.20M Beat $68.40M Estimate

Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 15 percent. This is a 21.05 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $76.20 million which beat the analyst consensus estimate of $68.40 million by 11.41 percent. This is a 18.78 percent increase over sales of $64.15 million the same period last year.